![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
BL Robbins, MC Connelly, DR Marshall, RV Srinivas and A Fridland
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.
9-(2-Phosphonylmethoxyethyl)adenine (PMEA) is a new antiviral agent with activity against herpes viruses and retroviruses, including human immunodeficiency virus, but its metabolism and mechanism of action remain unclear. We have isolated a human T lymphoid cell line (CEMr-1) that is resistant to the antiproliferative effects of PMEA. The antiviral effects of PMEA against human immunodeficiency virus-1 infection were also greatly reduced in CEMr-1 cells, compared with the parental cells. This mutant showed cross-resistance to the related acyclic nucleoside phosphonates 9-(2- phosphonylmethoxyethyl)diaminopurine and 9-(2- phosphonylmethoxyethyl)guanine and the lipophilic prodrug bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine-( bispome- PMEA), as well as partial resistance to the purine nucleosides 2- chlorodeoxyadenosine, 2-fluro-9-beta-D-arabinosylfuranosyladenine, and adenosine, but did not show resistance to 2'-deoxyadenosine or 9-beta-D- arabinosylfuranosyladenine. We compared the uptake and metabolism of [3H]PMEA and [3H]-bispom-PMEA in the mutant and parental cells. The analysis of radioactive products by high pressure liquid chromatography revealed marked alterations in the ability of the mutant cell line to accumulate PMEA and its anabolites, compared with the parental cells. Accumulation of PMEA, PMEA monophosphate, and PMEA bisphosphate (major metabolites formed with either PMEA or bispom-PMEA) decreased by 50, 95, and 97%, respectively. Compared with the parental cells, the variant cells showed a approximately 7-fold increase in the rate of efflux of PMEA and a 2-fold decrease in the activity of adenylate kinase. In contrast, other enzymes of nucleotide metabolism, such as adenosine kinase, deoxycytidine kinase, and 5-phosphoribosyl-1- pyrophosphate synthetase, showed no significant change in the two cell lines. Overall, these results suggest that the mutation in this resistant cell line is of a novel type, involving an alteration in the cellular efflux of PMEA as the major basis for the resistant phenotype.
This article has been cited by other articles:
|
|
 |
|
  A. S. Ray, T. Cihlar, K. L. Robinson, L. Tong, J. E. Vela, M. D. Fuller, L. M. Wieman, E. J. Eisenberg, and G. R. Rhodes Mechanism of active renal tubular efflux of tenofovir. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3297 - 3304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dallas, L. Schlichter, and R. Bendayan Multidrug Resistance Protein (MRP) 4- and MRP 5-Mediated Efflux of 9-(2-Phosphonylmethoxyethyl)adenine by Microglia J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1221 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Adachi, J. Sampath, L.-b. Lan, D. Sun, P. Hargrove, R. Flatley, A. Tatum, M. Z. Edwards, M. Wezeman, L. Matherly, et al. Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing J. Biol. Chem., October 4, 2002; 277(41): 38998 - 39004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lee, A. J. P. Klein-Szanto, and G. D. Kruh Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells J Natl Cancer Inst, December 6, 2000; 92(23): 1934 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wijnholds, C. A. A. M. Mol, L. van Deemter, M. de Haas, G. L. Scheffer, F. Baas, J. H. Beijnen, R. J. Scheper, S. Hatse, E. De Clercq, et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs PNAS, June 6, 2000; (2000) 120159197. [Abstract] [Full Text]
|
|
|
|
|
|
O. Turriziani, P. Di Marco, G. Antonelli, F. Dianzani;, and R. V. Srinivas May the Drug Transporter P Glycoprotein Affect the Antiviral Activity of Human Immunodeficiency Virus Type 1 Proteinase Inhibitors? Antimicrob. Agents Chemother., February 1, 2000; 44(2): 473 - 474. [Full Text]
|
|
|
|
 |
|
 P. Kramata and K. M. Downey 9-(2-Phosphonylmethoxyethyl) Derivatives of Purine Nucleotide Analogs: A Comparison of Their Metabolism and Interaction with Cellular DNA Synthesis Mol. Pharmacol., December 1, 1999; 56(6): 1262 - 1270. [Abstract] [Full Text]
|
|
|
|
|
|
S. Hatse, E. De Clercq, and J. Balzarini Enhanced 9-(2-Phosphonylmethoxyethyl)adenine Secretion by a Specific, Indomethacin-Sensitive Efflux Pump in a Mutant 9-(2-Phosphonylmethoxyethyl)adenine-Resistant Human Erythroleukemia K562 Cell Line Mol. Pharmacol., November 1, 1998; 54(5): 907 - 917. [Abstract] [Full Text]
|
|
|
|
|
|
P. Kramata, K. M. Downey, and L. R. Paborsky Incorporation and Excision of 9-(2-Phosphonylmethoxyethyl)guanine (PMEG) by DNA Polymerase delta and epsilon in Vitro J. Biol. Chem., August 21, 1998; 273(34): 21966 - 21971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Robbins, R. V. Srinivas, C. Kim, N. Bischofberger, and A. Fridland Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9-R-(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA Antimicrob. Agents Chemother., March 1, 1998; 42(3): 612 - 617. [Abstract] [Full Text]
|
|
|
|
|
|
V. M. Pisarev, S.-H. Lee, M. C. Connelly, and A. Fridland Intracellular Metabolism and Action of Acyclic Nucleoside Phosphonates on DNA Replication Mol. Pharmacol., July 1, 1997; 52(1): 63 - 68. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-S. Chen, K. Lee, and G. D. Kruh Transport of Cyclic Nucleotides and Estradiol 17-beta -D-Glucuronide by Multidrug Resistance Protein 4. RESISTANCE TO 6-MERCAPTOPURINE AND 6-THIOGUANINE J. Biol. Chem., August 31, 2001; 276(36): 33747 - 33754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wijnholds, C. A. A. M. Mol, L. van Deemter, M. de Haas, G. L. Scheffer, F. Baas, J. H. Beijnen, R. J. Scheper, S. Hatse, E. De Clercq, et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs PNAS, June 20, 2000; 97(13): 7476 - 7481. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
